Trial Profile
A phase I study of SMT C1100 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2015
Price :
$35
*
At a glance
- Drugs Ezutromid (Primary)
- Indications Duchenne muscular dystrophy
- Focus Pharmacokinetics
- 16 Jul 2015 New trial record